secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioCardia, Inc. (BCDA)
CIK:        0000925741
Form:       8-K
Filed at:   2026-06-08T12:00:11+00:00
Accession:  0001437749-26-019789
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioCardia raises $4.4M via ATM share sale, extends cash runway into Q1 2027
---------------------------------------------------------------------------

- Sold 3,509,604 shares at average $1.279 on June 5, 2026; net proceeds ~$4.4M.
- Proceeds expected to extend cash runway into Q1 2027, beyond planned Japan PMDA submission.
- If outstanding warrants from prior financings exercised for cash, runway would extend beyond PMDA approval into first commercial sales.
- No warrants were issued in this capital raise.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/925741/000143774926019789/0001437749-26-019789-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/925741/000143774926019789/bcda20260607_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-019789

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer